Last updated: November 1, 2023
Sponsor: National Taiwan University Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Adenocarcinoma
Treatment
Whipple over the splenic artery
Total pancreatectomy
Clinical Study ID
NCT06119776
202004002RINA
Ages > 20 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- pancreatic ductal cell adenocarcinoma (PDCA) patients
Exclusion
Exclusion Criteria:
- Patient undergoing palliative pancreatectomy, other malignancies with distantmetastases
- Vulnerable groups
Study Design
Total Participants: 70
Treatment Group(s): 2
Primary Treatment: Whipple over the splenic artery
Phase:
Study Start date:
May 20, 2020
Estimated Completion Date:
May 20, 2025
Study Description
Connect with a study center
National Taiwan University Hospital
Taipei,
TaiwanActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.